HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jason A Somarelli Selected Research

Jason A Somarelli Research Topics

Disease

30Neoplasms (Cancer)
12/2024 - 09/2014
12Prostatic Neoplasms (Prostate Cancer)
01/2023 - 09/2014
8Sarcoma (Soft Tissue Sarcoma)
01/2024 - 10/2016
7Neoplasm Metastasis (Metastasis)
01/2024 - 08/2016
6Osteosarcoma (Osteogenic Sarcoma)
01/2022 - 01/2020
5Circulating Neoplastic Cells
02/2021 - 03/2017
3Melanoma (Melanoma, Malignant)
06/2023 - 01/2020
3Carcinoma (Carcinomatosis)
01/2021 - 01/2019
2Colorectal Neoplasms (Colorectal Cancer)
12/2020 - 06/2020
1Neuroblastoma
12/2024
1Breast Neoplasms (Breast Cancer)
10/2023
1Margins of Excision
02/2022
1Thalassemia
01/2022
1COVID-19
01/2022
1Fibrosis (Cirrhosis)
01/2022
1Hepatocellular Carcinoma (Hepatoma)
01/2022
1Infarction (Infarctions)
01/2022
1Intellectual Disability (Idiocy)
01/2022
1Necrosis
01/2022
1Chromosomal Instability (Chromosome Stability)
10/2021
1Ischemia
01/2021
1Chondroblastoma
01/2021
1Hypoxia (Hypoxemia)
01/2021
1Giant Cell Tumor of Bone
01/2021
1Infections
03/2020
1Lung Neoplasms (Lung Cancer)
02/2019
1Disease Progression
01/2019
1Wounds and Injuries (Trauma)
01/2013
1Autoimmune Diseases (Autoimmune Disease)
07/2010

Drug/Important Bio-Agent (IBA)

7enzalutamideIBA
01/2023 - 08/2016
5Biomarkers (Surrogate Marker)IBA
01/2022 - 09/2014
4Androgen Receptors (Androgen Receptor)IBA
01/2023 - 08/2016
4Hormones (Hormone)IBA
01/2023 - 01/2019
4AndrogensIBA
01/2023 - 02/2021
3Indicators and Reagents (Reagents)IBA
01/2024 - 01/2019
3Immune Checkpoint InhibitorsIBA
06/2023 - 02/2021
3RNA (Ribonucleic Acid)IBA
01/2023 - 01/2021
3abirateroneIBA
01/2023 - 03/2017
3Messenger RNA (mRNA)IBA
01/2021 - 01/2019
2Phenobarbital (Luminal)FDA Link
10/2023 - 01/2023
2psymberinIBA
01/2023 - 01/2022
2Abiraterone AcetateIBA
01/2023 - 02/2021
2DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2020
2Transcription Factors (Transcription Factor)IBA
01/2022 - 08/2016
2Radium-223IBA
01/2020 - 01/2019
2Proteins (Proteins, Gene)FDA Link
01/2020 - 01/2019
2Cadherins (E-Cadherin)IBA
01/2019 - 09/2014
1darolutamideIBA
01/2023
1Aurora Kinase CIBA
01/2023
1apalutamideIBA
01/2023
1Adenosine Triphosphate (ATP)IBA
01/2023
1Polo-like KinasesIBA
01/2023
1avelumabIBA
01/2022
1IntegrinsIBA
01/2022
1NucleotidesIBA
10/2021
1LigandsIBA
02/2021
1Prednisone (Sone)FDA LinkGeneric
02/2021
1Oxygen (Dioxygen)IBA
01/2021
1ManganeseIBA
01/2021
1PorphyrinsIBA
01/2021
1LeukotrienesIBA
01/2021
1DenosumabFDA Link
01/2021
1RANK LigandIBA
01/2021
1Versicans (Versican)IBA
01/2021
1Proteasome Endopeptidase Complex (Proteasome)IBA
11/2020
1CytokinesIBA
03/2020
1Bortezomib (Velcade)FDA Link
01/2020
1ProdrugsIBA
01/2020
1StearatesIBA
01/2020
1Cell-Free Nucleic AcidsIBA
01/2020
1AntigensIBA
01/2020
1NiclosamideFDA Link
01/2020
1Transforming Growth Factors (Transforming Growth Factor)IBA
02/2019
1Alkaline PhosphataseIBA
01/2019
1Epithelial Cell Adhesion MoleculeIBA
03/2017
1MicroRNAs (MicroRNA)IBA
10/2016
1NexusIBA
08/2016
1Protein Isoforms (Isoforms)IBA
01/2013
1AutoantigensIBA
07/2010

Therapy/Procedure

26Therapeutics
12/2024 - 07/2010
5Castration
01/2022 - 03/2017
4Radiotherapy
01/2023 - 01/2019
4Precision Medicine
12/2020 - 03/2017
3Surgical Amputation (Amputations)
02/2022 - 10/2020
3Immunotherapy
01/2022 - 03/2020
1Length of Stay
02/2022
1Neoadjuvant Therapy
01/2022
1Drug Therapy (Chemotherapy)
10/2020
1Limb Salvage
10/2020